Personal information

Verified email domains

vaccine, hepatitis C, Zika, flavivirus, JEV, nucleic acid vaccines, mRNA, DNA
Australia

Activities

Employment (1)

University of Adelaide: Adelaide, SA, AU

2011-02 to present | Postdoctoral Research Fellow (Surgery)
Employment
Source: Self-asserted source
Branka Grubor-Bauk

Education and qualifications (1)

University of Adelaide: Adelaide, SA, AU

2002 to 2008 | PhD (Microbiology and Immunology )
Education
Source: Self-asserted source
Branka Grubor-Bauk

Professional activities (2)

South Australian Health and Medical Research Institute: Adelaide, SA, AU

2017-05 to present | Associate Research Fellow
Invited position
Source: Self-asserted source
Branka Grubor-Bauk

Young Investigator Award: Adelaide, SA, AU

2005 | Young Investigator of The Year
Distinction
Source: Self-asserted source
Branka Grubor-Bauk

Funding (15)

Zika Vaccine Study Proposal

2019-03 to 2019-06 | Contract
N4Pharma (Chellaston, Derbyshire, GB)
GRANT_NUMBER:

N4 Pharma, UK

Source: Self-asserted source
Branka Grubor-Bauk

A novel Zika virus DNA vaccine that provides complete protection from infection.

2019-02 to 2019-12 | Grant
University of Adelaide, Commercialisation Accelerator Scheme (SA, SA, AU)
Source: Self-asserted source
Branka Grubor-Bauk

A pre-clinical evaluation of an innovative DNA-based vaccination regimen to protect women of childbearing age against Zika virus during sexual transmission

2019-01 to 2020-12 | Grant
Channel 7 Children's Research Foundation (Adelaide, AU)
Source: Self-asserted source
Branka Grubor-Bauk

A pre-clinical evaluation of an innovative DNA-based vaccination regimen to protect women of childbearing age against Zika virus during sexual transmission

2019-01 to 2020-12 | Grant
The Hospital Research Foundation (Adelaide, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Barbara Kidman Women's Fellowship

2019-01 to 2019-12 | Grant
University of Adelaide (SA, SA, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Barbara Kidman Women's Fellowship

2019-01 to 2019-12 | Grant
The Hospital Research Foundation (Adelaide, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Novel Zika vaccine

2019-01 to 2019-12 | Grant
The Hospital Research Foundation (Adelaide, AU)
Source: Self-asserted source
Branka Grubor-Bauk

HCV challenge studies in vaccinated mice

2018-06 to 2019-06 | Grant
Australian Centre for HIV and Hepatitis Virology Research (NSW, NSW, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Identification of a diagnostic marker for assessment and management of psoriasis.

2018-06 to 2018-12 | Grant
New Adventures Fund, University of South Australia (adelaide, AU)
Source: Self-asserted source
Branka Grubor-Bauk

A multigenotypic HCV DNA Vaccine

2017-06 to 2018-06 | Grant
Australian Centre for HIV and Hepatitis Virology Research (NSW, NSW, AU)
Source: Self-asserted source
Branka Grubor-Bauk

A DNA vaccine to induce protective neutralizing antibodies to the HIV Tat protein

2016-07 to 2017-06 | Grant
The Hospital Research Foundation (Adelaide, SA, AU)
Source: Self-asserted source
Branka Grubor-Bauk

A DNA vaccine for Zika virus

2016-01 to 2018-12 | Grant
National Foundation for Medical Research and Innovation (Highton, VIC, AU)
Source: Self-asserted source
Branka Grubor-Bauk

DNA vaccine therapy for HCV

2014 to 2015 | Grant
The Hospital Research Foundation (Adelaide, SA, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Optimisation of HCV vaccine design

2014 to 2015 | Grant
he Hospital Research Foundation . (Adelaide, SA, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Development of a cytolytic HCV vaccine and a novel challenge model to test efficacy

2012 to 2013 | Grant
Australian Centre for HIV and Hepatitis Virology Research (NSW, NSW, AU)
Source: Self-asserted source
Branka Grubor-Bauk

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)